“…Photodynamic therapy (PDT) makes use of external light or laser to activate photosensitizers (PSs) and molecular oxygen to generate reactive oxygen species (ROS, e.g., singlet oxygen ( 1 O 2 ), superoxide anion radical ( • O 2 – ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical ( • OH)) to trigger noninvasive killing of cancer cells. − It is of immense advantage in terms of more precise selectivity, less drug resistance, and mitigating damage to healthy tissues and organs adjacent to tumor. − In consequence, it is prevailing with encouraging clinical efficacy against superficial skin tumors, esophageal, esophageal, bladder or lung cancer, and so forth. − PDT efficacy is positively correlated with the ROS-producing capacity of PSs, which is one of the three essential constituents in PDT (PSs, light, and oxygen). In this regard, preferable intersystem crossing (ISC) of PSs in the photosensitization process should be one of the molecular design guidelines . Since then, majority of small-molecule PSs, such as porphyrins, chlorins, methylene blue, and phthalocyanine derivatives, have been discussed.…”